Gem Pharmaceuticals, LLC
Records under this name other than patents Gem Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Gem Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,776,832 | Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,450,340 | 3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,158,591 | Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines Formerly held Term ended Ended no later than Apr 21, 2026 · From the USPTO record | Term ended | Ended no later than Apr 21, 2026 | From the USPTO record |
| US 7,244,829 | Compositions and processes for preparing 13-deoxy-anthracyclines Formerly held Term ended Term ended Jul 29, 2025 · From the USPTO record | Term ended | Term ended Jul 29, 2025 | From the USPTO record |
| US 7,772,379 | Compositions and processes for preparing 13-deoxy-anthracyclines Formerly held Term ended Term ended Dec 31, 2024 · From the USPTO record | Term ended | Term ended Dec 31, 2024 | From the USPTO record |
| US 8,097,707 | Compositions and processes for preparing 13-deoxy-anthracyclines Formerly held Term ended Ended no later than Nov 8, 2024 · From the USPTO record | Term ended | Ended no later than Nov 8, 2024 | From the USPTO record |
| US 5,942,605 | 5-Imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them Formerly held Term ended Term ended no later than Aug 24, 2019 · Low confidence | Term ended | Term ended no later than Aug 24, 2019 | Low confidence |
| US 5,948,896 | Processes for preparing 13-deoxy anthracycline derivatives Formerly held Term ended Term ended no later than Sep 7, 2019 · Low confidence | Term ended | Term ended no later than Sep 7, 2019 | Low confidence |